Delivery Order SPE2DR25D2012-SPE2DR26F1BPG
Award Date 12/18/25
Potential Completion Date 12/19/25
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,051.80 to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 mL auto-injector, a testosterone replacement therapy medication. The order, issued on November 3, 2025, with completion due by November 4, 2025, represents a firm fixed-price delivery under a competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,936.96 delivery order on July 23, 2025, for XYOSTED 75 mg/0.5 mL auto-injector units (0.5 mL). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 24, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under the company's larger pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,131.13 to AmerisourceBergen Drug Corp for XYOSTED 100 mg/0.5 ml auto-injector units, with an ultimate completion date of October 31, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $1,525.53 delivery order to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 mL auto-injectors on December 18, 2025, with completion scheduled for December 19, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,158.00 to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 mL auto-injector supplies. The contract, awarded on September 22, 2025, represents a firm fixed-price delivery order with an ultimate completion date of September 23, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was not set-aside and was competitively awarded, consistent with...
- The Defense Logistics Agency (DLA) awarded a $1,285.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XYOSTED 100 mg/0.5 mL auto-injector supplies, with a completion date of April 22, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is the vendor's corporate office in...
- The Defense Logistics Agency awarded a $1,044.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XYOSTED 100 mg/0.5 mL auto-injector units, with an ultimate completion date of November 6, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. Performance...
- The Defense Logistics Agency awarded a delivery order valued at $1,064.75 to AmerisourceBergen Drug Corp for XYOSTED 75 MG/0.5 ML auto-injector units on November 10, 2025, with completion scheduled for November 12, 2025. This firm fixed-price delivery order, executed without a set-aside designation, represents a competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania operations. The contract calls for the supply of testosterone replacement therapy auto-injectors to...
- The Defense Logistics Agency awarded a delivery order valued at $1,062.43 to AmerisourceBergen Drug Corp for the supply of XYOSTED 50 mg/0.5 ml auto-injector units. The contract is a firm fixed price delivery order with an ultimate completion date of August 22, 2025, awarded on August 21, 2025, with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Xyosted 100 mg/0.5 mL auto-injector (testosterone replacement therapy) with a ceiling value of $1,577.70. This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 10, 2025, and performance to be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order represents a child contract issued under...